Today's Updates

Daily Briefing

August 20, 2025

The Daily Briefing

A must-read daily newsletter for thousands of healthcare executives across the nation

IN THIS EDITION

Spotlight

Future-proof your service lines with our latest research

Shifting payer dynamics, evolving demographics, and more complex patient needs are upending traditional service line strategies. That's why we've collected the latest research to help you build resilient, future-ready service lines so you can thrive in today's healthcare landscape.

Webinar on Aug. 28 | Modernize your service line strategy, part 1: Governance
Webinar on Sept. 9 | Modernize your service line strategy, part 2: Growth
Ready-to-use slides | Specialty care market trends
Benchmarking tool | Service line benchmarking grids
Podcast | Service lines playlist

Next step: Turn strategy into action. Discover how our custom research can support your service line transformation.

Daily Briefing

Medical mystery: Diabetes, color-blindness lead to rare genetic diagnosis

A fit, middle-aged woman began losing her ability to see colors while her blood sugar inexplicably climbed — a baffling combination of symptoms that set her on a long search for answers, Rachel Zimmerman reports for The Washington Post.

August 20, 2025

Daily Briefing

Health policy roundup: HHS revives childhood vaccine safety panel

HHS last week announced plans to revive the Task Force on Safer Childhood Vaccines, which was originally disbanded in 1998 — a decision that has been praised by anti-vaccine activists, in today's roundup of the news in healthcare politics.

August 20, 2025

Daily Briefing

Hospitals have cut surgical mortality, boosted safety since pandemic

According to a new analysis from the American Hospital Association and Vizient, hospitals significantly improved mortality rates for surgical patients and performed better on patient safety measures in the first quarter of 2024 compared to before the pandemic.

August 20, 2025

Daily Briefing

Around the nation: FDA approves Wegovy for severe liver disease

FDA has approved Novo Nordisk's GLP-1 drug Wegovy as a treatment for a severe form of fatty liver disease, in today's bite-sized hospital and health industry news from Georgia, Illinois, and Maryland.

August 20, 2025

RELATED RESOURCES

Podcast

Radio Advisory

Radio Advisory is your weekly download on how to untangle healthcare's most pressing challenges, powered by 40 years of Advisory Board research.

Research & Insights

Senior care

Thousands of people age into America’s senior population every day, challenging the healthcare industry to develop sustainable and equitable care models for managing this growing population. Our research explores the changing demographics of the senior population, areas of innovation and need, and opportunities for each industry stakeholder to improve senior care.

Value-based care

The value-based care (VBC) movement — intended to shift the industry away from volume-based reimbursement — has been slow thus far. The next decade of value-based care must be different. Our research explores the barriers to value-based care and identifies key action steps that each industry stakeholder can take to drive progress.

Research

17 things CEOs need to know in 2025

Advisory Board’s “State of the Industry” research equips all healthcare executives with the knowledge and insights to capitalize on today’s business opportunities and mitigate tomorrow’s market risks.

We help leaders and future leaders in the healthcare industry work smarter and faster by providing provocative insights, actionable strategies, and practical tools to support execution.

Today's Updates

FEATURED INSIGHTS

RESOURCES BY SECTOR

NEWS & INSIGHTS

PRODUCTS & SERVICES

FEATURED CONTENT

Site-of-care shifts: Healthcare’s $50B opportunity

AskAdvisory

Care Delivery

Strategy

Staffing & Operations

Technology & Innovation

The life sciences and provider leader’s guides to today’s top obesity care trends

6 pitfalls to avoid when planning an EHR implementation

5 ways UNC Health made VBC work

FORECASTING & DEMAND

COMPETITION & MARKET SHARE

PERFORMANCE IMPROVEMENT & BENCHMARKING

POST-ACUTE CARE & NETWORK DESIGN

ADVISORY BOARD EVENTS

Upcoming Events:

WEBINARS

Upcoming Webinars:

Research Membership

ASKADVISORY

The Daily Briefing

Spotlight

Future-proof your service lines with our latest research

Medical mystery: Diabetes, color-blindness lead to rare genetic diagnosis

Health policy roundup: HHS revives childhood vaccine safety panel

Hospitals have cut surgical mortality, boosted safety since pandemic

Around the nation: FDA approves Wegovy for severe liver disease

Subscribe to the Daily Briefing

Radio Advisory

Senior care

Value-based care

17 things CEOs need to know in 2025

Research & Events

Company

Support

Social

Don't miss out on the latest Advisory Board insights

Want access without creating an account?

Become a member to access all of Advisory Board's resources, events, and experts

Benefits include:

Become a member to access all of Advisory Board's resources, events, and experts

Benefits include:

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Benefits Include:

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Benefits Include: